Shockwave Medical Inc
NASDAQ:SWAV
Shockwave Medical Inc
NASDAQ:SWAV
Price:
330.59 USD
-0.01%
Market Closed
Updated:
May 9, 2024
EV/EBITDA
Enterprise Value to EBITDA
Enterprise Value to EBITDA
70.6
Current
56
Median
12.6
Industry
Higher
than median
Higher
than industry value
Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.
EV/EBITDA
=70.6
Enterprise Value
/
12B
EBITDA
169.5m
All Countries
| Market Cap | EV/EBITDA | ||||
|---|---|---|---|---|---|
| US |
|
Shockwave Medical Inc
NASDAQ:SWAV
|
12.2B USD | 70.6 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
182B USD | 19.1 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
136.7B USD | 56.5 | |
| US |
|
Stryker Corp
NYSE:SYK
|
126B USD | 24.3 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
109.7B USD | 13.9 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
108.6B USD | 30.9 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
68B USD | 18.7 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
58.5B EUR | 18.5 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
52.7B USD | 27.1 | |
| US |
|
Dexcom Inc
NASDAQ:DXCM
|
50.7B USD | 59.2 | |
| CN |
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
367.2B CNY | 28.2 |
EV/EBITDA Forward Multiples
Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.
1-Year Forward
EV/EBITDA
46
2-Years Forward
EV/EBITDA
33.9
3-Years Forward
EV/EBITDA
26.7
You don't have any saved screeners yet
